European Archives - Page 113 of 1210 - European Medical Journal

Young Stroke Survivors: Who Is Most at Risk for Poststroke Epilepsy?

Young adults face a low but notable risk of epilepsy after stroke, with risk factors well-predicted by current scores.

John Riches

Hema Now: Episode 15: Understanding B cell Metabolism in Lymphoma

John Riches, Clinical Reader in Cancer Immunometabolism, Barts Cancer Institute; Honorary Consultant Haemato-oncologist, Barts Health NHS Trust, London, UK, discusses how metabolism could conquer lymphoma.

Diabetes Medications Show Promise in Dementia Prevention

Newer diabetes drugs linked to reduced risk of dementia in older adults, real-world data shows promising results.

Infectious Disease Diagnostics: Superbugs, Zoonotic Threats, and the Next Pandemic

In the second episode of our special miniseries, Jonathan is joined by molecular epidemiologist Rodney Rohde to explore diagnostic innovations in the fight against antimicrobial resistance and gaps in zoonotic disease detection.

Seasonal Immunotherapy: Safe to Start During Pollen Peaks?

The study suggests that initiating Artemisia annua SLIT during the pollen season is just as safe and well-tolerated as starting it before.

24 Apr 2025

Case Report of a Patient Presenting with Acute Flank Pain

A female in her 40s, with a history of heavy smoking presented to the emergency department with a 6-hour history of paraesthesia and…

Probiotics Improve Liver Function During Chemotherapy

A recent study explored the combined impact of oral nutritional supplementation and probiotics on gut microbiota and liver function.

Biomimetic Hydrogels Revolutionise CAR T Cancer Therapy Production

Biomimetic hydrogels boost CAR T cell production by 50%, cutting cancer therapy costs.

Caffeine Could Help Reduce Cardiovascular Risk in Lupus

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

Breakthrough Study Links Parasitic Infection to Cervical Cancer Risk

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.